GDF15 and obesity due to melanocortin 4 receptor deficiency: The interactions between GDF15 and lipid metabolism suggest that it may hold therapeutic potential for obesity and relevant metabolic diseases, although further investigations are needed to clarify its precise mechanisms and long-term effects (and side effects).